• Sudhakar Bangera
  • Latha Ms


For biopharmaceutical companies, in order to prevent excessive expenditure, completing a clinical trial on time is a very important factor. Selection of
the right study site(s), trained investigators and site coordination team are key factors in determining timely completion of the study. There are few
criteria (study and sponsor specific) that have to be met by sites to allow them to qualify and participate in the study. By adhering to these, the value of
the sponsor's time and money can be enhanced. Though site selection in India is similar to that in other countries, there are a few cultural differences
that the sponsors should be aware of. Based on our experiences, we provide guidance here to address practical issues that may be encountered while
selecting a site and an investigator in India. Study sites in India have the potential to become world-class study sites, but require an infrastructure
and proper training. With an available patient pool along with an unmet health need, Indian sites offer an attractive alternative to their foreign
Keywords: Clinical trial, Infrastructure, Investigator, Site selection, Training.


India: Attractive Market for Biopharmaceutical Companies Looking
to Accelerate Their Clinical Trials, Articles base. Available from:
their-clinical-trials-754610.html. [Last accessed on
2011 Nov 15; Posted on Feb 03].
2. People and lifestyle: Ethnicity of India-culture and heritage-know India:
National portal. New Delhi: National Portal Content Management
Team,; Ethnicity of India. Available from: http://www. [Last updated on
2010 Jan 22].
3. Varawalla NY, Jain R, Stern D. Market report: Effective utilisation of
India for global clinical trials. J Clin Stud 2011;2(3):30-4.
952 Views | 1223 Downloads
How to Cite
Bangera, S., and L. Ms. “SITE SELECTION FOR CLINICAL RESEARCH IN INDIA”. Asian Journal of Pharmaceutical and Clinical Research, Vol. 8, no. 1, Jan. 2015, pp. 10-14,
Review Article(s)